NEW CDC GUIDELINES : 5 YEAR-OLD CAN RECEIVE UP TO 19 VACCINATIONS IN ONE MONTH Mandatory vaccines are only there to force parents under threats to kill their kids.

by Christina England Health Impact NewsOn November 2, 2017, Neil Z. Miller made an online announcement that was guaranteed to shock thousands of parents worldwide.

In a post, written on the popular social media platform Facebook, Miller exposed that the Centers for Disease Control and Prevention (CDC) had recently hatched a plan to ensure that ALL children were up to date with their scheduled vaccinations, whether they were vaccinated or unvaccinated.

He revealed that the CDC had launched a catch-up program which could cause an unvaccinated 5-year-old to receive as many as 19 vaccinations in one month.He wrote that:

Citation:

“The CDC has just launched a program that will calculate a catch-up schedule for children who were not vaccinated on schedule. A 5-year-old child who was not previously vaccinated would be required to receive 19 vaccines in one month, including 6 doses of aluminum-containing injections! This catch-up schedule was NOT tested for safety to determine the immediate or long-term risk of neurological or immunological damage.” (own emphasis)

Following the links provided by Miller, it appears that the CDC table of vaccinations required in their catch-up program had been approved by the following organizations:Advisory Committee on Immunization Practices – (www.cdc.gov/vaccines/acip)American Academy of Pediatrics – (www.aap.org)American Academy of Family Physicians – (www.aafp.org)American College of Obstetricians and Gynecologists – (www.acog.org)

See tables here.Could their latest step be yet another one of the many underhanded tactics used by the CDC to implement mandatory vaccination?Higher Number of Vaccinations Equals Higher Number of Infant DeathsThat number of vaccinations administered in such a short time frame could potentially kill a young child, and if anyone would know how dangerous administering 19 vaccinations in one month could be, it would be Neil Z. Miller.

Their paper highlighted the fact that the countries with the highest number of vaccinations on their schedule were the same countries that had the highest number of infant mortalities.Using a number of tables, the researchers were able to determine that the number of infant deaths appeared to coincide with the number of vaccinations being administered in each country.Through rigorous research, they discovered that the lower the number of vaccines being recommended, the lower the number of infant deaths.

They wrote:

Citation:

“The infant mortality rate is expressed as the number of infant deaths per 1000 live births. According to the US Central Intelligence Agency (CIA), which keeps accurate, up-to-date infant mortality statistics throughout the world, in 2009 there were 33 nations with better infant mortality rates than the United States.”

They determined that in 2009, a total of 26 vaccine doses were recommended for children under the age of one in the U.S. The team then compared the number of vaccine doses being recommended in each country against the number of infant deaths.

From their calculations, they were able to determine that not only did the U.S. recommend the highest number of vaccinations, but that they also had the highest number of infant deaths.

Since 2009, the number of vaccinations being recommended to infants has significantly increased. According to recent reports, the U.S. vaccination schedule currently recommends that children receive a total of 56 injections of 73 doses of 30 different vaccines beginning on day one of their life.

It would be interesting to know if the infant mortality rate has continued to rise, just as Miller had predicted.

Miller’s 2011 paper was not the only paper in which he made it abundantly clear that multiple vaccinations could endanger the life of a young child.

Using data taken from the Vaccine Adverse Event Reporting System (VAERS) website, Miller was able to prove that the more vaccines a child received at any given time, the more likely an adverse reaction could occur.

They wrote that:

Citation:

“… Of the 38,801 VAERS reports that we analyzed, 969 infants received two vaccine doses prior to the adverse event and 107 of those infants were hospitalized: a hospitalization rate of 11%. Of 1,959 infants who received three vaccine doses prior to the adverse event, 243 of them required hospitalization: 12.4%. For four doses, 561 of 3,909 infants were hospitalized: 14.4%.Notice the emerging pattern: Infants who had an adverse event reported to VAERS were more likely to require hospitalization when they received three vaccine doses instead of two, or four vaccine doses instead of three.”

The researchers continued:

Citation:

“… Of 10,114 infants who received five vaccine doses prior to the adverse event, 1,463 of them required hospitalization: 14.5%. For six doses, 1,365 of 8,454 infants were hospitalized: 16.1%. For seven doses, 1,051 of 5,489 infants were hospitalized: 19.1%. And for eight doses, 661 of 2,817 infants were hospitalized: 23.5%. The hospitalization rate increased linearly from 11.0% for two doses to 23.5% for eight doses.”

In other words, the more vaccines that an infant received, the more likely they were to suffer an adverse reaction.Miller and Goldman explained that:

Citation:

“Of the 38,801 VAERS reports that we analyzed, 11,927 infants received one, two, three, or four vaccine doses prior to having an adverse event, and 423 of those infants died: a mortality rate of 3.6%. The remaining 26,874 infants received five, six, seven, or eight vaccine doses prior to the adverse event and 1,458 of them died: 5.4%.

The mortality rate for infants who received five to eight vaccine doses (5.4%) is significantly higher than the mortality rate for infants who received one to four doses (3.6%), with a rate ratio(RR) of 1.5 (95% CI, 1.4-1.7).

Of infants reported to VAERS, those who had received more vaccines had a statistically significant 50% higher mortality rate compared with those who had received fewer.”

Unvaccinated Baby Died When Doctor Guessed Number of Vaccines He Should Receive

Bently.

Sadly, Miller was correct, because in 2015, I wrote the tragic story of six month-old Bently, who died after his doctor made an “educated” guess and administered 13 vaccinations in one day. I wrote:

Citation:

“Imagine being emotionally blackmailed by your doctor to have your baby vaccinated with a lethal cocktail of 13 vaccines, which included two doses of the DTaP, three doses of the oral rotavirus vaccine and two doses of the polio vaccination. It sounds impossible, doesn’t it?”

However, this is exactly what happened to Alisa Neathery when she took her six month-old unvaccinated baby to the doctor for the first time.She told VacTruth:

Citation:

“Prior to the shots being given, when the doctor was discussing the pros of getting vaccinated with me, he explained how he was from a village in Africa.

That we were lucky in America to have the opportunity to receive vaccines because where he was from, the mothers had to have like 11 kids each, since most would die off from disease because they were not as fortunate to receive vaccines like we are here in America.

He really pushed them on me hard. He spent a lot of time convincing me to give Bently the vaccines, but when it was done, we never saw the doctor again.”

According to Alisa, the doctor spent a long time deciding exactly which vaccinations Bently should receive and told Alisa that they shouldn’t give him too many. The doctor eventually decided on a total of 13 vaccinations, which Alisa now believes led to Bently’s death just five days later.

You can listen to Alisa’s tragic story in full, as she explained to Richie Allen exactly what happened on the day she decided to have her child vaccinated.

With Alisa’s story in mind, we asked Miller if he could comment on the CD

Alisa Neathery: "A GP Gave My Baby 13 Vaccines At Once. He Died In My Arms 5 Days Later!"

On 25 November 2017, a shipment of vaccines is delivered to the Sana’a International airport, bringing in15 tonnes of BCG, Penta and PCV vaccine supplies to protect Yemeni children from diseases such as diphtheria and tetanus. UNICEF/UN0147212/Madhok

21 December 2017 – A plane charted by the United Nations Children’s Fund (UNICEF) landed in Sana’a, Yemen, on Thursday, delivering nearly 6 million doses of essential vaccines to protect millions of children at risk of preventable diseases, including the current diphtheria outbreak that has reportedly infected over 300 people and killed 35.

“Vaccinating children in Yemen now is critical to protect them from preventable diseases and death. It is vital that vaccines and other lifesaving supplies for children continue to flow into Yemen and across the country unimpeded. They are a lifeline for millions of children,” said Meritxell Relaño, UNICEF Representative in Yemen. Most diphtheria cases and deaths are among children.

Since 2015, the southern Arabian nation has been in a conflict between forces loyal to President Abdrabbuh Mansour Hadi and those allied to the Houthi rebel movement.

The country is in the grips of the world’s worst humanitarian crisis, with restrictions on fuel and food imports further complicating emergency response.

The restrictions add to the misery of children in Yemen who already face the triple threat of diseases, malnutrition and violence.

UNICEF reiterates its call on all parties to allow unhindered humanitarian access to all of Yemen’s land, sea and air ports and to facilitate the distribution of lifesaving assistance for children inside the country.

This year, deaths from flu shots have increased dramatically. Doctors are completely willfully ignorant as to the deaths from vaccines or even what ingredients are in vaccines, yet they all prescribe it because they too profit from giving vaccines to all. Educate yourself. Protect your children.

The Government of Zambia has launched a campaign on Wednesday (January 10) to vaccinate residents of Lusaka against cholera with support from the World Health Organization and partners.

Two million doses of the oral cholera vaccine from the Gavi-funded global stockpile were delivered to the southern African country in January, enough to immunize 1 million people. = Bill Gates foundation

According to Health Minister Dr Chitalu Chilufya, the campaign will bring the life-saving oral cholera vaccine to the people who need it most. He also highlighted the role that communities can play in preventing the spread of the disease. “Communities should not ignore basic preventative measures because the key drivers of this epidemic include consumption of contaminated water and food, poor waste management, and poor personal hygiene practices which have to change,” said Dr Chilufya.

Cholera is an acute diarrhoeal disease that can kill within hours if left untreated. Since the start of the current outbreak on 4 October 2017, the Ministry of Health reports that there have been a total of 2,672 cases, with Lusaka alone accounting for 2,558 cases. There have been 63 deaths countrywide, 58 of which in Lusaka.

WHO is working with the Zambia National Public Health Institute (ZNPHI) to address the underlying causes of the cholera outbreak: clean water provision, sanitation and health education on personal hygiene. WHO is also helping authorities to track down cases, treat cholera patients and provide community health education.

Selected vaccination sites in central areas of Lusaka will be targeted under the campaign. WHO has provided training to medical personnel in how to administer the vaccine, as well as on other preventive measures and cholera treatment.

“Zambia is experiencing one of the worst outbreaks of cholera in years,” said Dr. Nathan Bakyaita, WHO Representative to Zambia. “With this campaign, we can stop cholera in its tracks and prevent an even more devastating epidemic.”

While sporadic cases of cholera are regular occurrences in Zambia during the five-month rainy season, the number of cases this year has exceeded the average annual caseload.

WHO recommends that vaccination against cholera be considered in emergencies and other high-risk scenarios where there are increased threats of outbreaks, when combined with standard prevention and control measures for the disease. These measures include readiness to provide adequate testing and treatment, steps to ensure access to safe water and sanitation, and community mobilization to engage the public in preventing infection.

Planning is underway to vaccinate a further 1 million people living in known cholera hotspots across the country later this year.

For Additional Information or to Request Interviews, Please contact:Nora Mweemba

Our 2016–2020 mission, to save children’s lives and protect people’s health by increasing equitable use of vaccines in lower-income countries, is guided by four strategic goals

In June 2014, the Gavi Board approved a new five-year strategy to ensure we deliver on our overall mission for 2016–2020. Full implementation of the strategy will see developing countries immunise 300 million children, saving 5–6 million lives in the long term.Coverage and equity are at the core of our strategy. While we continue to support countries to introduce new vaccines, our focus is expanding to reach every child with these vaccines. With as many as 20 countries transitioning out of our financial support in this period, ensuring that programmes are sustainable in the long term is essential.

Gavi's strategy is a roadmap designed to help us respond to changes in the vaccine landscape and set five-year milestones en route to fulfilling our mission. The 2016-2020 strategy is the latest in four distinct phases since our inception:

This section details the strategic objectives and operating principles for the current phase (2016-2020) as well as providing an overview of previous strategies.

You can also learn more about our vaccine investment strategy, which we use to determine which vaccines are made available to countries through our vaccine support programmes. A new strategy is developed every five years, when we take stock of available and expected vaccines and set new priorities through in-depth analysis and widespread consultations. The latest vaccine investment strategy was developed in 2013 and covers the period 2014-2018.

According to the Center for Disease Control and Prevention (CDC), this year’s flu season is now as bad as the 2009-2010 “Swine Flu Epidemic” that affected more than 60 million Americans... With some reports noting how this current "record flu season" has resulted up to 4,000 American deaths per week.

There were 40,414 deaths in the U.S. during the third week of 2018, the most recent data available, and 4,064 were from pneumonia or influenza, according to the CDC data… In Jan. 2018, Florida has now recently announced a bill that would make it mandatory for children to receive the HPV vaccine. Of course, Florida is not the only state — as there are multiple school districts and companies that are also striving to make vaccines mandatory for schooling and for employment.

But what is the REAL Cause behind the flu, and much of these diseases?

Could all of the Governmental Alphabet Soups such as the CDC, Department of Health and Human Services (DHHS), World Health Organization (WHO), and also the Food and Drug Administration (FDA) ALSO play a role in such a grand scheme worldwide?

How does this apply to the United Nations (U.N.) Agenda 21/Agenda 2030 when it comes to Operation Depopulation?

Could mandatory vaccinations also play a role in Walmart, FEMA, quarantines, martial law, and even in the end times to come?!?!

THE TRUTH REVEALED!!! STAY AWARE OF THE WORLD AROUND YOU!!!! AND AVOID VACCINES!

AND AS ALWAYS, PLEASE SEEK YAHUAH AND HIS TRUE SON YAHUSHA — FOR EVEN MORE TRUTH!!

According to CDC (Centers for Disease Control and Prevention), this year's dominant strain is H3N2, which is far more severe than other previous strains, leading to more extreme, and often fatal, symptoms. = Their reasons : less than 20 percent effective, mutation. My question : What do they put in the H3N2 vaccine who now kill thousands of peoples?

According to Anna Treague, a health official for Public Health, the severity of H3N2 has been caused by mutations in the virus that are triggered by influenza vaccinations. In a statement to ABC news, Treague confirmed that this year's flu strain, that has left thousands of citizens dead, was caused by the vaccines itself, saying: "I believe that the low effective rate of the vaccine this year is due to the mutations that the virus made in the processing of the vaccine itself.

Treague clearly states that the vaccination is at "LEAST" part of the problem, if not the WHOLE problem. Other health experts agree with Teague statement, including Dr. Mercola, who is one of the world's leading authorities on the dangers of vaccines. Speaking about the mutations caused by the vaccines, Mercola says, "it’s no surprise at all." Dr. Mercola isn't alone with his prognosis, as countless other medical professionals, MDs, and PhDs all agree.

Even though the flu shot has only be found to be 10% effective against this year's strain, the government still insists that it's imperative that every citizen is vaccinated, despite the clear dangers. How would the families of those already killed after receiving the shot respond to that news?

The answer?

According to allopathic medicine, we should rush to see our doctor as soon as we experience so they can treat us with antiviral medication.

The dangers of Tamiflu are no secret though, and it can only shorten the duration by 12 hours. The recommended course of action is to stay home and not spread the virus. Symptoms usually appear after 1-3 days of being infected, and most people usually recover in under a week. Just don’t ignore your symptoms though, which include chills, fever, headache, dry cough and aching of joints and muscles.

“The world needs to prepare for pandemics in the same serious way it prepares for war,” Gates warned the audience.

Futurism.com reports: Each year, the Massachusetts Medical Society and the New England Journal of Medicine present an event featuring panelists and speakers focused on a specific health-related topic. This year, that topic was epidemics. What better speaker than Bill Gates, whose foundation strives to combat some of the biggest threats to public health, such as HIV and malaria? During his presentation, Gates looked to the past, present, and future of our outbreak preparedness.

The short version: We’ve come a long way, but still have a long way to go.

Back in 1889, the Russian flu became the first flu pandemic to spread across continents. A few decades later, the 1918 flu pandemic killed 675,000 people in just five weeks. Luckily for those of us alive now, today we have vaccines, drugs, and diagnostic tools that help us address outbreaks far more effectively than when those illnesses first took hold.

But we still fall short in so many respect, according to Gates.

He noted the “wake up calls” of the 2009 H1N1 virus and West Africa’s more recent Ebola outbreak. The world didn’t respond quickly enough in either situation. We couldn’t effectively track the diseases as they spread. Our local health systems simply collapsed. People kept dying because we weren’t ready.

“The world needs to prepare for pandemics in the same serious way it prepares for war,” Gates told the audience.

One way to be better prepared for the inevitable next pandemic: to develop better weapons to fight outbreaks. To that end, the Bill & Melinda Gates Foundation has teamed up with the family of Google co-founder and Alphabet CEO Larry Page to launch the Universal Influenza Vaccine Development Grand Challenge.

According to the challenge website, the goal is to find a “game changing, universal solution” to address both pandemic and seasonal influenza. The World Health Organization (WHO) estimates 290,000 to 650,000 people die from the latter each year, and while less common, pandemic influenza can be even more deadly.

The Grand Challenge will award $250,000 to $2 million in funding over two years to the most promising proposals for a universal flu vaccine. Then, those projects that “demonstrate promising proof-of-concept data,” such as success in animal models, can apply for a full award of $10 million for additional studies.

The Gates Foundation is thinking big and fast with this challenge. They’re only interested in a universal flu vaccine — not one that might work to address certain strains of the flu or in certain populations — and they want it to be ready for clinical trials by 2021.

We may not meet the Hollywood standard for outbreak preparedness today, but if Bill Gates has anything to say about it, we might in the very near future.

Four years ago, the world was stunned by the Ebola outbreak in West Africa. Panic broke out all over the globe. Governments scrambled to contain the infection. By the time the last patient tested negative for the disease, the outbreak claimed thousands of lives and caused billions of dollars in economic losses.

The 2014 Ebola outbreak was a stark reminder of how vulnerable our society is to epidemics of infectious diseases. We weren’t ready then, and we’re still not ready now—but we can be. We don’t know when the next epidemic will strike, but I believe we can protect ourselves if we invest in better tools, a more effective early detection system, and a more robust global response system.

When the Massachusetts Medical Society asked me to deliver this year’s Shattuck Lecture, I knew I wanted to talk about epidemic preparedness. I was honored to address their annual meeting earlier today. Here is the full text of my prepared remarks:

Remarks as delivered Shattuck Lecture April 27, 2018 Boston, MA

BILL GATES:

Thank you, Dr. Drazen, for that kind introduction. It’s an honor to be invited to deliver the Shattuck Lecture.

Most of the speeches I give on global health are about the incredible progress and exciting new tools that are helping the world reduce child mortality and tackle infectious diseases. Thanks to better immunization and other interventions, child mortality has been reduced by more than 50 percent since 1990. We are on the verge of eradicating polio. HIV is no longer a certain death sentence. And half the world is now malaria-free.

So usually, I’m the super-optimist, pointing out that life keeps getting better for most people in the world.

There is one area, though, where the world isn’t making much progress, and that’s pandemic preparedness. This should concern us all, because if history has taught us anything, it’s that there will be another deadly global pandemic.

We can’t predict when. But given the continual emergence of new pathogens, the increasing risk of a bioterror attack, and how connected our world is through air travel, there is a significant probability of a large and lethal, modern-day pandemic occurring in our lifetimes.

Watching Hollywood thrillers, you’d think the world was pretty good at protecting the public from deadly microorganisms. We like to believe that somewhere out there, there is a team ready to spring into action – equipped with the latest and best technologies.

Government agents like Jack Bauer in 24. Harvard professors like Robert Langdon in Inferno. And WHO epidemiologists like Dr. Leonora Orantes in Contagion – who even risked getting kidnapped as she pursued “Patient Zero.”

In the real world, though, the health infrastructure we have for normal times breaks down very rapidly during major infectious disease outbreaks. This is especially true in poor countries. But even in the U.S., our response to a pandemic or widespread bioterror attack would be insufficient.

Several things in the last decade have made me pay closer attention to the risk of future pandemics. One was the outbreak of Swine Flu in 2009. While H1N1 wasn’t as lethal as people initially feared, it showed our inability to track the spread of disease and develop new tools for public health emergencies.

The Ebola epidemic in West Africa four years ago was another wake-up call. As confirmed cases climbed, the death toll mounted, and local health systems collapsed. Again, the world was much too slow to respond.

And, as biological weapons of mass destruction become easier to create in the lab, there is an increasing risk of a bioterror attack.

What the world needs – and what our safety, if not survival, demands – is a coordinated global approach. Specifically, we need better tools, an early detection system, and a global response system.

Today, I’d like to speak with you about some of the advances in tools – vaccines, drugs, and diagnostics – that make me optimistic we can get a leg up on the next pandemic. And I’ll talk about some of the gaps we must address in preparedness and response.

Interestingly, the first Shattuck Lecture – given back in 1890 – focused on a pandemic . . . the Russian flu that struck Massachusetts the previous year. The Russian flu was not especially deadly. But it was the first flu pandemic to spread across continents connected by rail travel – and between continents connected by fast ocean liners. The virus circled the globe in just four months.

But the world was soon in for much worse. Less than 30 years later, the Boston area was one of the first places in the U.S. to feel the deadly effects of the 1918 flu. Military personnel getting off and on ships at the Commonwealth Pier – near where we are meeting today – helped carry the pathogen across the U.S. and back to the battlefields of World War I.

This animation shows how quickly the virus spread across the United States. It took five weeks and killed 675,000 people.

The death toll was so great that average life expectancy in the U.S. for that period dropped by 12 years.

We have better tools today than we did a century ago. We have a seasonal flu vaccine, although it’s not always effective, you have to get one every year, and most people in the world never get the shot. We also have antibiotics for secondary infections of bacterial pneumonia.

Despite these advances, this animated simulation by the Institute for Disease Modeling shows what would happen if a highly contagious and lethal airborne pathogen – like the 1918 flu – were to occur today.

Nearly 33 million people worldwide would die in just six months.

That’s the sobering news. The good news is that scientific advances and growing interest on the federal level, in the private sector, and among philanthropic funders makes development of a universal flu vaccine more feasible now than 10 or 20 years ago.

Our foundation is involved in a variety of research partnerships, including a collaboration between the Icahn School of Medicine at Mount Sinai, GlaxoSmithKline, and PATH.

Their work focuses on several vaccine candidates that did well in animal trials and which are now in human trials.

We are also supporting efforts by others, including the National Institute of Allergy and Infectious Diseases, whose vaccine candidate is expected to advance to human safety trials in about a year.

To broaden efforts even further, today we are launching a $12 million Grand Challenge in partnership with the Page family to accelerate the development of a universal flu vaccine. The goal is to encourage bold thinking by the world’s best scientists across disciplines, including those new to the field.

Lucy and Larry Page are also supporting efforts by the Sabin Vaccine Institute to encourage innovative approaches that eliminate the threat of a deadly flu pandemic.

However, the next threat may not be a flu at all. More than likely, it will be an unknown pathogen that we see for the first time during an outbreak, as was the case with SARS, MERS, and other recently-discovered infectious diseases.

The world took an important step last year to begin addressing this risk with the launch of a public-private partnership called the Coalition for Epidemic Preparedness Innovations (CEPI).

With funding commitments of more than $630 million, CEPI’s first order of business is advancing the development of vaccines for three of the priority diseases on the WHO list for public health R&D: Lassa fever, Nipah virus, and Middle East Respiratory Syndrome.

CEPI is also working on rapid-response platforms to produce safe, effective vaccines for a range of infectious diseases – almost as quickly as new threats emerge. Later this year, CEPI will announce grants to several companies working with a variety of technologies – including nucleic acid vaccines, viral vectors, and other innovative approaches. The goal is to be able to develop, test, and release new vaccines in a matter of weeks or months, rather than years.

I’m a big fan of vaccines, but they may not be the answer when we have to respond immediately to rapidly spreading infectious disease pandemics. Not only do vaccines take time to develop and deploy; they also take at least a couple of weeks after the vaccination to generate protective immunity. So, we need to invest in other approaches like antiviral drugs and antibody therapies that can be stockpiled or rapidly manufactured to stop the spread of pandemic diseases or treat people who have been exposed.

Earlier this year, the Shionogi pharmaceutical company received approval in Japan for a new influenza anti-viral, Xofluza This single-dose drug stops flu in its tracks by inhibiting an enzyme that the virus needs to multiply.

And PrEP Biopharm, a development stage biopharmaceutical company, has demonstrated in human challenge studies that pre-activating the innate immune response through intranasal delivery of a double-stranded viral RNA “mimic” can prevent both influenza and rhinovirus.

Since the host’s innate immune response is non-virus specific, such an approach has the potential to offer protection against other types of respiratory viruses as well.

Monoclonal antibody therapies have also made incredible advances in the last couple of decades, leading to several products for cancer and autoimmune diseases. During the Ebola outbreak in West Africa several years ago, researchers were able to identify and test a promising combination of monoclonal antibodies to treat infected patients.

And a growing pipeline of broadly neutralizing antibodies are being discovered in some individuals exposed to infectious diseases. For example, a small percentage of people infected with HIV develop antibodies with high potency and breadth of coverage sufficient to protect against many strains of the virus. The same is true for some people infected with the flu. Different sets or cocktails of these exceptional antibodies may protect against a pandemic strain of a virus even if it has genetically evolved. It is conceivable that we could create libraries of these antibodies, produce manufacturable seed stocks, and have them ready for immediate use in an outbreak—or ready to scale up manufacturing if a pandemic ensues. If we can learn how to use RNA or DNA gene delivery effectively, we may not need to make the antibodies at all.

Rapid diagnosis is also critical, especially at the beginning of an outbreak when quarantine, treatment, and other public health measures are most effective. To that end, researchers at the Broad Institute and at UC-Berkeley have developed a highly-sensitive point-of-care diagnostic test that harnesses the powerful genetic engineering technology known as CRISPR.

But instead of using CRISPR to edit DNA, they have programmed an associated protein called Cas13 to hunt for specific pieces of RNA. When Cas13 locates the relevant genetic sequence, it releases a signal molecule that indicates the presence or absence of the target.

In a paper published yesterday in the journal, Science, the Broad researchers highlighted the field-use potential of this new diagnostic. Using paper strips similar to a pregnancy test – and with minimal sample processing – the diagnostic can check a patient’s blood, saliva, or urine for evidence of a pathogen.

What’s more, it can test for multiple pathogens at once. It could, for example, identify if someone is infected with Zika or dengue virus, which have similar symptoms.

There are also some interesting advances that leverage the power of computing to help predict where pandemics are likely to emerge and model different approaches to preventing or containing them.

Over the last few years, researchers at the Institute for Health Metrics and Evaluation at the University of Washington have developed a sophisticated computer model that combines data from dozens of sources with geospatial mapping to predict the pandemic risk of infectious diseases.

They recently looked at the pandemic potential of four viral hemorrhagic fevers in Africa – including Ebola. Their analysis confirmed that Guéckédou prefecture in Guinea – where the West African Ebola outbreak originated – was indeed one of the most likely places where an individual Ebola case could lead to a widespread epidemic.

The research also pinpointed dozens of other African communities that are at high risk of outbreaks of hemorrhagic fevers.

Meanwhile, researchers at the Institute for Disease Modeling are pushing the boundaries of computational epidemiology to provide a deeper understanding of both the spread of infectious diseases and the effectiveness of different control and eradication strategies.

In the effort to eliminate malaria, for example, IDM is combining surveillance data with computational modeling to tailor antimalarial efforts to unique local conditions. They are also using quantitative analysis and modeling to evaluate various control strategies for HIV, TB, and to eradicate polio. This kind of research could provide valuable information to help predict disease transmission and identify prevention measures and intervention tactics for epidemics and pandemics.

At the Munich Security Conference last year, I asked world leaders to imagine that somewhere in the world, there is a weapon that exists – or that could emerge – that is capable of killing millions of people, bringing economies to a standstill, and casting nations into chaos.

If this were a military threat, the response – of course – would be that we should do everything possible to develop countermeasures. In the case of biological threats, that sense of urgency is lacking.

The world needs to prepare for pandemics the way the military prepares for war. This includes simulations and other preparedness exercises so we can better understand how diseases will spread and how to deal with things like quarantine and communications to minimize panic.

We need better coordination with military forces to ensure we can draw on their mobilization capacity to transport people, equipment, and supplies on a mass scale.

We need a reserve corps of trained personnel and volunteers, ready to go at a moment’s notice. And we need manufacturing and indemnification agreements in place with pharmaceutical companies –with expedited review processes for government approval of new treatments.

Last month, Congress directed the administration to come up with a comprehensive plan to strengthen global health security – here and abroad. This could be an important first step if the White House and Congress use the opportunity to articulate and embrace a leadership role for the U.S. in global health security.

No other country has the depth of scientific or technical expertise that we do – drawing on the resources of institutions like the NIH, the CDC, and advanced research organizations like DARPA and BARDA.

Our biopharmaceutical industry is the global leader in biomedical innovation. And, on the world stage, the U.S. is an influential member of international forums like the UN, the WHO, the G7, and the G20.

The point is that the U.S. can and should play a leadership role in creating the kind of pandemic preparedness and response system the world needs.

As I said at the start, I’m fundamentally an optimist, and that gives me hope that we can get prepared for the next big pandemic.

The global community eradicated smallpox, a disease that killed an estimated 300 million people in the 20th century alone.

We are on the verge of eradicating polio, a disease that 30 years ago was endemic in 125 countries and that paralyzed or killed 350,000 people a year.

And today, nearly 21 million people are receiving life-saving HIV treatment, thanks primarily to the support of the world community.

America’s global HIV initiative, PEPFAR, was the catalyst for world action on the AIDS crisis. It’s an example of the kind of leadership we need from the U.S. on a broader effort to make the world safer from other infectious disease threats. With strong bipartisan support, PEPFAR has saved millions of lives and shown that national governments can work together to address pandemics.

Somewhere in the history of these collective efforts is a roadmap to create a comprehensive pandemic preparedness and response system.

We must find it and follow it because lives – in numbers too great to comprehend – depend on it.

The physician who served as Bill Gates’ private doctor in Seattle in the 1990s says the Microsoft founder and vaccine proponent “refused to vaccinate his own children” when they were young.

“I don’t know if he had them vaccinated as adults, but I can tell you he point blank refused to vaccinate them as children,” the physician said at a behind closed doors medical symposium in Seattle, adding “They were gorgeous kids, really smart and vivacious, and he said they would be OK as it was, they didn’t need any shots.“

The comments caused a stir among physicians at the symposium with claims he was breaking doctor-patient confidentiality, according to reports. However as he was speaking to other physicians, he was not breaking the industry code of conduct.

Gates has three children with his wife Melinda – Jennifer, Rory and Phoebe – born between 1996 and 2002, and according to his former doctor, they are all unvaccinated and healthy.

The news that Bill Gates does not vaccinate his own children, despite being the world’s most active campaigner for mandatory vaccinations, should come as no surprise. Studies prove that the elite do not vaccinate their children. But at the same time they expect the masses to have their children vaccinated.

The elite do not vaccinate

In California, the children most likely to be unvaccinated are white and come from the wealthiest families in Los Angeles, according to a recent study.

The percentage of kindergartners with state-issued personal belief exemptions doubled from 2007 to 2013, from 1.54% to 3.06%. That’s about 17,000 of the wealthiest children, out of more than half a million, opting out of receiving vaccinations.

Vaccine exemption percentages were highest in mostly white, high-income neighborhoods such as Orange County, Santa Barbara and parts of the Bay Area, according to CNN.

The study, which was published in the American Journal of Public Heath, looked at more than 6,200 California schools and found vaccine exemptions were twice as common among kindergartners attending private institutions.

“Very rich and privileged parents like the idea of herd immunity, but they don’t want to take the risks associated with vaccinations when it comes to their own children. They are worried about adverse reactions including autism.“

In this Newsbud exclusive interview Spiro’s guest is Michelle Krinsky, who is a registered nurse with 36 years experience. They discuss how Krinsky was fired for refusing to take a mandated flu shot after she had experienced an adverse event the previous year after receiving the vaccine. They also cover the potential motives behind this mandate and Ohio House Bill 193, which aims to protect employees from being forced to take the flu shot to maintain employment.

Australia has begun imposing extreme financial sanctions on parents who refuse to vaccinate their children, taking out money from their bank accounts every 2 weeks.

Parents will now lose $28 (£16) every fortnight for each child that is not up to date with their immunizations.

Independent.co.uk reports: The new fortnightly sanction will see parents lose out on roughly the same amount but is said to serve as a more “constant reminder”. Those earning over A$80 a day will also have further penalties imposed.

The move is part of an ongoing clampdown by the Australian government on the “anti-vaxxer” movement after the percentage of children under seven with a “conscientious objection” to immunisation rose from 0.23 per cent in December 1999 to 1.77 per cent in December 2014, according to Australia’s parliament.

Minister for Social Services Dan Tehan said the clampdown was necessary to protect public health.

“Immunisation is the safest way to protect children from vaccine-preventable diseases,” he said in a statement, news.com.au reported. “Parents who don’t immunise their children are putting their own kids at risk as well as the children of other people.”

It comes as a leading medical journal in the UK found measles “remains a threat” to the British public after 643 cases were recorded up to 18 June this year, up from 274 cases in the whole of 2017.

In September last year, the World Health Organisation (WHO) declared that measles had been eliminated in the UK. The UK also reached the WHO target for 95 per cent of five-year-olds to receive the first dose of the measles, mumps, and rubella (MMR) vaccine.

But the journal found there had been several outbreaks of measles across Europe in countries where MMR uptake has been low historically, including Romania, France, Greece, and Italy, with 48 measles deaths reported in the European Union since 2016.

Lead author Dr Maliha Moten, who is part of Public Health England’s West Midlands Health Protection Team, said the latest British cases are “mainly linked to importations from Europe”.

Uptake of the MMR vaccine fell heavily in the late 1990s following the publication of research by Andrew Wakefield which suggested a possible link between the inoculation and autism. Experts have widely discredited his study and he was struck off the medical register in 2010.

PHE said that while vaccine uptake levels in the UK in young children are currently very high, coverage levels dipped to a low of 80 per cent in 2003, meaning significant numbers of unprotected teenagers and young adults could contract measles.

Dr Mary Ramsay, head of immunisation at Public Health England, said: “In the early 2000s there was a fall in MMR vaccination coverage in children and as a consequence, we are now seeing measles cases in young adults.

“Measles can be more serious in adults with a higher likelihood of hospitalisation and complications arising.

“Measles is circulating in England and the rest of Europe. We often think about what travel-related vaccines we might need before going on holiday, but it’s also important to check that we are up to date with routine vaccinations like MMR.

“If you are unsure if you have had two doses of MMR call your GP practice to check and catch up if needed.”

Judy Mikovits, PhD is a biochemist and molecular biologist with more than 33 years of experience. Internationally known, a veritable “rock star” of the scientific world, she served as the director of the lab of Antiviral Drug Mechanisms at the National Cancer Institute before directing the Cancer Biology program at EpiGenX Pharmaceuticals. She later developed the first neuroimmune institute. Her early work focused on cancer and HIV, her latest on Chronic Fatigue Syndrome and autism. She has published more than 50 peer-reviewed articles.

In 2011, she made the discovery that destroyed her career. She found that at least 30% of our vaccines are contaminated with gammaretroviruses. Not only is this contamination associated with autism and chronic fatigue syndrome, it is also associated with Parkinson’s, Lou Gehrig’s disease, and Alzheimer’s.

When she released this shocking information, she was warned by Dr. Andrew Wakefield that she would become a target, just as he had been. But she assured him that all of her work had been properly reviewed and, of course, she was safe.

She was wrong. She was threatened and told to destroy her data; she refused. She was fired, then arrested for supposedly stealing her data from her worksite. She had been facing charges and was bound by a gag order from the court for the last four years. Recently, charges were dropped and the gag order was lifted. Dr. Mikovits is now free to talk, and boy is she talking.

The retroviruses contaminating vaccines originate from mice used for research. Dr. Mikovits asks, “How many new retroviruses have we created through all the mouse research, the vaccine research, gene therapy research? More importantly, how many new diseases have we created?”

“When they destroyed all of our work, and discredited everything I or Frank Ruscetti had ever published, and arranged for the publication of my mug shot in Science, the NIH very deliberately sent the message to researchers everywhere about what would happen to any honest scientist who dared ask those important questions.”

New technology now exists to clean up retroviruses in vaccines and blood. Dr. Mikovits believes we will win this war, that we will eventually clean up vaccines, stop vaccinating infants, and stop injecting our children with multiple vaccines. But she also believes the government will continue to cover up their culpability in the current epidemic of autism and other diseases.

When asked about vaccine-injured children, she says, “Those are the victims. And that’s why, I’m working and why, you know, I’ll never shut up. Because they’re the victims that have been hung out to dry.”

Dr. Mikovits is clearly taking a stand against vaccination with today’s vaccines and the current vaccine schedule. Retroviruses are not her only concern. She talks about the effects of aluminum, mercury, formaldehyde, and polysorbate 80. She believes these neurotoxins play a definite part, along with retrovirus contamination, in the rise of several diseases in this country.

Due to the contamination of retroviruses and neurotoxins she doesn’t believe anyone should receive vaccines until vaccines are cleaned up. When that happens, we should only vaccinate for one disease at a time if and when needed. We also should never vaccinate anyone who does not have a healthy immune system, who has a family history of autoimmune diseases, or anyone who is currently ill.

To learn more about Dr. Mikovits’ work and how the government has attempted to silence her, check out her book, Plague, One Scientist’s Intrepid Search for the Truth about Human Retroviruses and Chronic Fatigue Syndrome (ME/CFS), Autism, and Other Diseases.INTERVIEW WITH DR. JUDY MIKOVITS, PhD, 11/22/15